Worldwide Clinical Trials partners with small to midsize biopharma sponsors to accelerate oncology drug development from first-in-human trials through regulatory approval. Our approach combines deep oncology expertise with operationally efficient global execution, enabling sponsors to launch complex trials quickly while maintaining scientific rigor and data quality. With more than 800 oncology-designated staff averaging 5+ years of specialized experience, we bring therapeutic depth across solid tumors, hematologic malignancies, and emerging modalities including ADCs, immuno-oncology, and cell & gene therapies. Our team operates with the agility and direct senior leadership access that sponsors need, backed by the infrastructure of a global CRO spanning 70 countries. Whether you need full-service support, hybrid models, or functional service provision, our teams deliver continuity through 90%+ project team retention and industry-leading startup speed.
Read our fact sheet to learn more about how Worldwide’s oncology expertise can support your clinical development program.
